Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Oncologist|June 26, 2025
New tool in the toolbox: patient selection for zolbetuximab in advanced treatment-naïve gastric/gastroesophageal junction adenocarcinomaUdhayvir S Grewal, Timothy J Brown
Med (New York, N.Y.)|November 15, 2025
Neuroendocrine neoplasm classification: The missing piece of the puzzleUdhayvir S Grewal, Calisia N Clarke, Razelle Kurzrock
The Yale Journal of Biology and Medicine|September 24, 2019
Role of Mitochondrial Markers in Improved Detection and Risk-Stratification in Barrett's Esophagus PatientsUdhayvir S Grewal, Mehraj S Randhawa, Aryan Mehta
Thoracic Cancer|January 9, 2025
Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial FibrillationStefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal
Current Treatment Options in Oncology|October 13, 2025
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine TumorsJeremy Chang, Udhayvir S Grewal, Scott K Sherman, et al.
Expert Review of Anticancer Therapy|July 31, 2024
Targeted therapies in advanced biliary malignancies: a clinical reviewUdhayvir S Grewal, Shiva J Gaddam, Muhammad S Beg, et al.
European Heart Journal. Case Reports|January 29, 2026
Bilateral carcinoid heart disease without intracardiac shunt in a patient with advanced functional small bowel neuroendocrine tumour: a clinical conundrumStefano H Byer, Mashkurul Haque, Ola Abdelkarim, et al.
Future Oncology (London, England)|March 31, 2025
Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101Udhayvir S Grewal, Olumide B Gbolahan, Amol M Takalkar, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 27, 2023
Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19Luna Acharya, Alpana Garg, Manoj Rai, et al.
The American Journal of Cardiology|February 8, 2025
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid CardiomyopathyStefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal, et al.
Pageof 3